Skip to main content

Arvinas, Inc.

ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001655759

No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Arvinas, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
216
+20 vs. Q4 2024
Shares held
65.1M
−9.85M (−13.1%) vs. Q4 2024
Total value
$456.7M
−$983.2M (−68.3%) vs. Q4 2024
New holders
56
72 more added
Sold out
36
60 more reduced

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 216 institutions
Q1 2021: 181 institutionsQ2 2021: 181 institutionsQ3 2021: 205 institutionsQ4 2021: 199 institutionsQ1 2022: 179 institutionsQ2 2022: 172 institutionsQ3 2022: 174 institutionsQ4 2022: 162 institutionsQ1 2023: 171 institutionsQ2 2023: 156 institutionsQ3 2023: 155 institutionsQ4 2023: 213 institutionsQ1 2024: 223 institutionsQ2 2024: 207 institutionsQ3 2024: 206 institutionsQ4 2024: 199 institutionsQ1 2025: 216 institutionsQ2 2025: 215 institutionsQ3 2025: 211 institutionsQ4 2025: 206 institutionsQ1 2026: 207 institutionsQ2 2026: 201 institutions
Value heldQ1 2025: $456.7M
Q1 2021: $2.88BQ2 2021: $3.52BQ3 2021: $3.64BQ4 2021: $3.69BQ1 2022: $3.16BQ2 2022: $2.08BQ3 2022: $2.22BQ4 2022: $1.71BQ1 2023: $1.34BQ2 2023: $1.16BQ3 2023: $959.0MQ4 2023: $2.67BQ1 2024: $2.84BQ2 2024: $1.89BQ3 2024: $1.78BQ4 2024: $1.47BQ1 2025: $456.7MQ2 2025: $513.8MQ3 2025: $570.7MQ4 2025: $662.9MQ1 2026: $572.6MQ2 2026: $468.7M
Institutions holding ARVN and their total value by quarter
QuarterHoldersValue
Q2 2026201$468.7M
Q1 2026207$572.6M
Q4 2025206$662.9M
Q3 2025211$570.7M
Q2 2025215$513.8M
Q1 2025216$456.7M
Q4 2024199$1.47B
Q3 2024206$1.78B
Q2 2024207$1.89B
Q1 2024223$2.84B
Q4 2023213$2.67B
Q3 2023155$959.0M
Q2 2023156$1.16B
Q1 2023171$1.34B
Q4 2022162$1.71B
Q3 2022174$2.22B
Q2 2022172$2.08B
Q1 2022179$3.16B
Q4 2021199$3.69B
Q3 2021205$3.64B
Q2 2021181$3.52B
Q1 2021181$2.88B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q4 2024.

Institutions holding ARVN in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Norges Bank1,007,912$7.08M0.00%−235,956−19.0%Reduced
Millennium Management LLC1,310,326$9.20M0.01%+995,483+316.2%Added
Tang Capital Management LLC1,393,800$9.78M0.54%+1,393,800New
Nextech Invest, Ltd.1,408,394$9.89M2.30%+1,408,394New
Geode Capital Management, LLC1,536,796$10.8M0.00%+25,782+1.7%Added
New Leaf Venture Partners, L.L.C.1,585,721$11.1M24.79%00.0%Unchanged
Alyeska Investment Group, L.P.1,800,000$12.6M0.05%+1,800,000New
State Street Corp1,896,190$13.3M0.00%+259,140+15.8%Added
Opaleye Management Inc.1,975,000$13.9M3.09%+350,000+21.5%Added
RTW Investments, LP3,334,308$23.4M0.36%00.0%Unchanged
Pfizer Inc3,457,815$24.3M4.85%00.0%Unchanged
Price T Rowe Associates Inc3,825,064$26.9M0.00%−277,947−6.8%Reduced
Citadel Advisors LLC3,875,846$27.2M0.03%+803,178+26.1%Added
BlackRock, Inc.6,169,602$43.3M0.00%−396,543−6.0%Reduced
Vanguard Group Inc8,362,200$58.7M0.00%+1,299,639+18.4%Added
DekaBank Deutsche Girozentrale42,000––00.0%Unchanged
EcoR1 Capital, LLC0$00.00%−6,726,491−100.0%Sold out
Bellevue Group AG0$00.00%−2,389,600−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−1,776,555−100.0%Sold out
Boxer Capital Management, LLC0$00.00%−1,058,614−100.0%Sold out
Perceptive Advisors LLC0$00.00%−740,749−100.0%Sold out
Logos Global Management LP0$00.00%−700,000−100.0%Sold out
Affinity Asset Advisors, LLC0$00.00%−630,000−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−503,936−100.0%Sold out
Wasatch Advisors Inc0$00.00%−436,241−100.0%Sold out
Ra Capital Management, L.P.0$00.00%−421,348−100.0%Sold out
Baker Bros. Advisors LP0$00.00%−405,576−100.0%Sold out
Panagora Asset Management Inc0$00.00%−297,186−100.0%Sold out
Frazier Life Sciences Management, L.P.0$00.00%−285,331−100.0%Sold out
BIT Capital GmbH0$00.00%−263,527−100.0%Sold out
American Century Companies Inc0$00.00%−252,685−100.0%Sold out
Neuberger Berman Group LLC0$00.00%−164,392−100.0%Sold out
Twinbeech Capital LP0$00.00%−164,112−100.0%Sold out
Ameriprise Financial Inc0$00.00%−116,513−100.0%Sold out
Parkman Healthcare Partners LLC0$00.00%−106,871−100.0%Sold out
Patient Square Capital LP0$00.00%−86,627−100.0%Sold out
Standard Life Aberdeen plc0$00.00%−78,585−100.0%Sold out
Bank of Montreal0$00.00%−39,407−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−39,063−100.0%Sold out
SG Americas Securities, LLC0$00.00%−32,424−100.0%Sold out
M&T Bank Corp0$00.00%−31,673−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−19,249−100.0%Sold out
DnB Asset Management AS0$00.00%−10,234−100.0%Sold out
Skandinaviska Enskilda Banken AB (publ)0$00.00%−9,806−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−3,601−100.0%Sold out
Coppell Advisory Solutions LLC0$00.00%−1,133−100.0%Sold out
Skopos Labs, Inc.0$00.00%−797−100.0%Sold out
Venturi Wealth Management, LLC0$00.00%−242−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−232−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−57−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−34−100.0%Sold out
Cornerstone Planning Group LLC0$00.00%−17−100.0%Sold out
Nextech Invest AG––––Not filed
Nuveen Asset Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed